Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiner Wiest

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Clinical and Experimental Medicine|July 27, 2017
Circulating fibroblast growth factor 21 in patients with liver cirrhosisSabrina Krautbauer, Lisa Rein-Fischboeck, Elisabeth M Haberl, et al.
Clinical and Experimental Medicine|February 21, 2020
Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patientsSusanne Feder, Elisabeth M Haberl, Marlen Spirk, et al.
Clinical Hemorheology and Microcirculation|March 1, 2014
Evaluation of treatment response after chemoembolisation (TACE) in hepatocellular carcinoma using real time image fusion of contrast-enhanced ultrasound (CEUS) and computed tomography (CT)--preliminary resultsHella Wobser, Reiner Wiest, Bernd Salzberger, et al.
Hepatology (Baltimore, Md.)|December 3, 2003
Bacterial translocation up-regulates GTP-cyclohydrolase I in mesenteric vasculature of cirrhotic ratsReiner Wiest, Gregory Cadelina, Sheldon Milstien, et al.
Digestion|September 25, 2019
Isoproterenol Disrupts Intestinal Barriers Activating Gut-Liver-Axis: Effects on Intestinal Mucus and Vascular Barrier as Entry SitesMarcel Sorribas, Andrea de Gottardi, Sheida Moghadamrad, et al.
Surgical Endoscopy|May 29, 2024
Antegrade balloon dilatation of the duodenal papilla during laparoscopic cholecystectomy versus endoscopic retrograde cholangiography in patients with acute choledocholithiasis: a case control matched studySeverin Gloor, Simone Minder, Bianca Schnell, et al.
Journal of Gastroenterology and Hepatology|August 11, 2007
Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical courseFrank Tacke, Christian Trautwein, Eray Yagmur, et al.
Nature Reviews. Gastroenterology & Hepatology|October 27, 2021
Cirrhosis-associated immune dysfunctionAgustín Albillos, Rosa Martin-Mateos, Schalk Van der Merwe, et al.
Scandinavian Journal of Gastroenterology|March 14, 2007
Improvement in the routine diagnostic assessment of the liver by high-resolution sonography: an analysis of 999 casesDoris Schacherer, Carola Schuh, Ulrike Strauch, et al.
Regulatory Peptides|September 11, 2012
Connective tissue growth factor level is increased in patients with liver cirrhosis but is not associated with complications or extent of liver injurySabrina Bauer, Kristina Eisinger, Reiner Wiest, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Clinical and Experimental Medicine|July 27, 2017
Circulating fibroblast growth factor 21 in patients with liver cirrhosisSabrina Krautbauer, Lisa Rein-Fischboeck, Elisabeth M Haberl, et al.
Clinical and Experimental Medicine|February 21, 2020
Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patientsSusanne Feder, Elisabeth M Haberl, Marlen Spirk, et al.
Clinical Hemorheology and Microcirculation|March 1, 2014
Evaluation of treatment response after chemoembolisation (TACE) in hepatocellular carcinoma using real time image fusion of contrast-enhanced ultrasound (CEUS) and computed tomography (CT)--preliminary resultsHella Wobser, Reiner Wiest, Bernd Salzberger, et al.
Hepatology (Baltimore, Md.)|December 3, 2003
Bacterial translocation up-regulates GTP-cyclohydrolase I in mesenteric vasculature of cirrhotic ratsReiner Wiest, Gregory Cadelina, Sheldon Milstien, et al.
Digestion|September 25, 2019
Isoproterenol Disrupts Intestinal Barriers Activating Gut-Liver-Axis: Effects on Intestinal Mucus and Vascular Barrier as Entry SitesMarcel Sorribas, Andrea de Gottardi, Sheida Moghadamrad, et al.
Surgical Endoscopy|May 29, 2024
Antegrade balloon dilatation of the duodenal papilla during laparoscopic cholecystectomy versus endoscopic retrograde cholangiography in patients with acute choledocholithiasis: a case control matched studySeverin Gloor, Simone Minder, Bianca Schnell, et al.
Journal of Gastroenterology and Hepatology|August 11, 2007
Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical courseFrank Tacke, Christian Trautwein, Eray Yagmur, et al.
Nature Reviews. Gastroenterology & Hepatology|October 27, 2021
Cirrhosis-associated immune dysfunctionAgustín Albillos, Rosa Martin-Mateos, Schalk Van der Merwe, et al.
Scandinavian Journal of Gastroenterology|March 14, 2007
Improvement in the routine diagnostic assessment of the liver by high-resolution sonography: an analysis of 999 casesDoris Schacherer, Carola Schuh, Ulrike Strauch, et al.
Regulatory Peptides|September 11, 2012
Connective tissue growth factor level is increased in patients with liver cirrhosis but is not associated with complications or extent of liver injurySabrina Bauer, Kristina Eisinger, Reiner Wiest, et al.
Pageof 12